{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T08:56:50Z","timestamp":1790758610447,"version":"4.1.0"},"reference-count":87,"publisher":"Elsevier BV","issue":"15","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progr\u00e8s en Urologie"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.purol.2015.07.016","type":"journal-article","created":{"date-parts":[[2015,10,28]],"date-time":"2015-10-28T14:34:55Z","timestamp":1446042895000},"page":"933-946","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Imagerie du cancer de la prostate\u00a0: IRM et imagerie nucl\u00e9aire"],"prefix":"10.1016","volume":"25","author":[{"given":"R.","family":"Renard Penna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Brenot-Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Salomon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Souli\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.purol.2015.07.016_bib0440","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1148\/radiol.2523081423","article-title":"Prostate tumor volume measurement with combined T2-weighted imaging and diffusion-weighted MR: correlation with pathologic tumor volume","volume":"252","author":"Mazaheri","year":"2009","journal-title":"Radiology"},{"key":"10.1016\/j.purol.2015.07.016_bib0445","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1148\/radiol.2482070157","article-title":"Prostate cancer: relationships between postbiopsy hemorrhage and tumor detectability at MR diagnosis","volume":"248","author":"Tamada","year":"2008","journal-title":"Radiology"},{"key":"10.1016\/j.purol.2015.07.016_bib0450","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1148\/radiol.10100667","article-title":"Is apparent diffusion coefficient associated with clinical risk scores for prostate cancers that are visible on 3-T MR images?","volume":"258","author":"Turkbey","year":"2011","journal-title":"Radiology"},{"key":"10.1016\/j.purol.2015.07.016_bib0455","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1148\/radiol.13130801","article-title":"Low-risk prostate cancer: the accuracy of multiparametric MR imaging for detection","volume":"271","author":"Kim","year":"2014","journal-title":"Radiology"},{"key":"10.1016\/j.purol.2015.07.016_bib0460","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1148\/radiol.11091409","article-title":"Relationship between apparent diffusion coefficients at 3.0-T MR imaging and Gleason grade in peripheral zone prostate cancer","volume":"259","author":"Hambrock","year":"2011","journal-title":"Radiology"},{"key":"10.1016\/j.purol.2015.07.016_bib0465","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1016\/j.juro.2012.07.024","article-title":"Magnetic resonance imaging for predicting prostate biopsy findings in patients considered for active surveillance of clinically low risk prostate cancer","volume":"188","author":"Vargas","year":"2012","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2015.07.016_bib0470","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.juro.2012.06.011","article-title":"Correlation of magnetic resonance imaging tumor volume with histopathology","volume":"188","author":"Turkbey","year":"2012","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2015.07.016_bib0475","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.juro.2013.12.006","article-title":"Tumor target volume for focal therapy of prostate cancer-does multiparametric magnetic resonance imaging allow for a reliable estimation?","volume":"191","author":"Cornud","year":"2014","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2015.07.016_bib0480","first-page":"5155","article-title":"Pathology of prostate cancer and focal therapy (\u2018male lumpectomy\u2019)","volume":"29","author":"Mazzucchelli","year":"2009","journal-title":"Anticancer Res"},{"key":"10.1016\/j.purol.2015.07.016_bib0485","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1148\/radiology.202.1.8988214","article-title":"Staging prostate cancer with MR imaging: a combined radiologist-computer system","volume":"202","author":"Seltzer","year":"1997","journal-title":"Radiology"},{"key":"10.1016\/j.purol.2015.07.016_bib0490","doi-asserted-by":"crossref","first-page":"845","DOI":"10.2214\/ajr.166.4.8610561","article-title":"Local staging of prostate cancer with endorectal MR imaging: correlation with histopathology","volume":"166","author":"Jager","year":"1996","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.purol.2015.07.016_bib0495","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1007\/s00330-012-2475-5","article-title":"Prediction of prostate cancer extracapsular extension with high spatial resolution dynamic contrast-enhanced 3-T MRI","volume":"22","author":"Bloch","year":"2012","journal-title":"Eur Radiol"},{"key":"10.1016\/j.purol.2015.07.016_bib0500","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.crad.2007.05.022","article-title":"The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer: a meta-analysis","volume":"63","author":"Hovels","year":"2008","journal-title":"Clin Radiol"},{"key":"10.1016\/j.purol.2015.07.016_bib0505","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1007\/s00330-011-2377-y","article-title":"ESUR prostate MR guidelines 2012","volume":"22","author":"Barentsz","year":"2012","journal-title":"Eur Radiol"},{"key":"10.1016\/j.purol.2015.07.016_bib0510","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.juro.2006.04.013","article-title":"Prostate saturation biopsy in the reevaluation of microfocal prostate cancer","volume":"176","author":"Boccon-Gibod","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2015.07.016_bib0515","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.juro.2009.10.009","article-title":"Pathological findings and prostate specific antigen outcomes after radical prostatectomy in men eligible for active surveillance \u2013 does the risk of misclassification vary according to biopsy criteria?","volume":"183","author":"Ploussard","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2015.07.016_bib0520","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.eururo.2012.06.044","article-title":"Validation of the European Society of Urogenital Radiology scoring system for prostate cancer diagnosis on multiparametric magnetic resonance imaging in a cohort of repeat biopsy patients","volume":"62","author":"Portalez","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.purol.2015.07.016_bib0525","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/bju.12690","article-title":"First round of targeted biopsies using magnetic resonance imaging\/ultrasonography fusion compared with conventional transrectal ultrasonography-guided biopsies for the diagnosis of localised prostate cancer","volume":"115","author":"Mozer","year":"2015","journal-title":"BJU Int"},{"key":"10.1016\/j.purol.2015.07.016_bib0530","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1148\/radiol.13121501","article-title":"Prostate cancer diagnosis: multiparametric MR-targeted biopsy with cognitive and transrectal US-MR fusion guidance versus systematic biopsy \u2013 prospective multicenter study","volume":"268","author":"Puech","year":"2013","journal-title":"Radiology"},{"key":"10.1016\/j.purol.2015.07.016_bib0535","first-page":"140184","article-title":"Prostate imaging reporting and data system and Likert scoring system: multiparametric MR imaging validation study to screen patients for initial biopsy","author":"Renard-Penna","year":"2015","journal-title":"Radiology"},{"key":"10.1016\/j.purol.2015.07.016_bib0540","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1148\/radiol.13122393","article-title":"Real-time contrast-enhanced transrectal US-guided prostate biopsy: diagnostic accuracy in men with previously negative biopsy results and positive MR imaging findings","volume":"269","author":"Cornelis","year":"2013","journal-title":"Radiology"},{"key":"10.1016\/j.purol.2015.07.016_bib0545","first-page":"128","article-title":"Closed-loop control in fused MR-TRUS image-guided prostate biopsy","volume":"10","author":"Xu","year":"2007","journal-title":"Med Image Comput Comput Assist Interv Int"},{"key":"10.1016\/j.purol.2015.07.016_bib0550","article-title":"First round of targeted biopsies using magnetic resonance imaging\/ultrasonography fusion compared with conventional transrectal ultrasonography-guided biopsies for the diagnosis of localised prostate cancer","author":"Mozer","year":"2014","journal-title":"BJU Int"},{"issue":"2","key":"10.1016\/j.purol.2015.07.016_bib0875","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1148\/radiol.13121501","article-title":"Prostate cancer diagnosis: multiparametric MR-targeted biopsy with cognitive and transrectal US-MR fusion guidance versus systematic biopsy\u2013prospective multicenter study","volume":"268","author":"Puech","year":"2013","journal-title":"Radiology"},{"key":"10.1016\/j.purol.2015.07.016_bib0560","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1148\/radiol.11103504","article-title":"Use of MR imaging to determine preservation of the neurovascular bundles at robotic-assisted laparoscopic prostatectomy","volume":"262","author":"McClure","year":"2012","journal-title":"Radiology"},{"key":"10.1016\/j.purol.2015.07.016_bib0565","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1148\/rg.333125041","article-title":"MR imaging of prostate cancer in radiation oncology: what radiologists need to know","volume":"33","author":"Boonsirikamchai","year":"2013","journal-title":"Radiographics"},{"key":"10.1016\/j.purol.2015.07.016_bib0570","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/bju.12243","article-title":"The role of magnetic resonance imaging (MRI) in focal therapy for prostate cancer: recommendations from a consensus panel","volume":"113","author":"Muller","year":"2014","journal-title":"BJU Int"},{"key":"10.1016\/j.purol.2015.07.016_bib0575","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1097\/RCT.0b013e31829ae20a","article-title":"Multiparametric magnetic resonance imaging characterization of prostate lesions in the active surveillance population: incremental value of magnetic resonance imaging for prediction of disease reclassification","volume":"37","author":"Bonekamp","year":"2013","journal-title":"J Comput Assist Tomogr"},{"key":"10.1016\/j.purol.2015.07.016_bib0580","article-title":"A prospective comparison of MRI-US fused targeted biopsy versus systematic ultrasound-guided biopsy for detecting clinically significant prostate cancer in patients on active surveillance","author":"Da Rosa","year":"2014","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.purol.2015.07.016_bib0585","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1148\/radiol.13121325","article-title":"Prostate cancer: can multiparametric MR imaging help identify patients who are candidates for active surveillance?","volume":"268","author":"Turkbey","year":"2013","journal-title":"Radiology"},{"key":"10.1016\/j.purol.2015.07.016_bib0590","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1007\/s00330-013-2768-3","article-title":"Prostate cancer recurrence after radical prostatectomy: the role of 3-T diffusion imaging in multi-parametric magnetic resonance imaging","volume":"23","author":"Panebianco","year":"2013","journal-title":"Eur Radiol"},{"key":"10.1016\/j.purol.2015.07.016_bib0595","doi-asserted-by":"crossref","first-page":"596","DOI":"10.2214\/AJR.11.7162","article-title":"Diffusion-weighted MRI for locally recurrent prostate cancer after external beam radiotherapy","volume":"198","author":"Morgan","year":"2012","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.purol.2015.07.016_bib0600","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1007\/s00330-009-1647-4","article-title":"Imaging of prostate cancer local recurrences: why and how?","volume":"20","author":"Rouviere","year":"2010","journal-title":"Eur Radiol"},{"key":"10.1016\/j.purol.2015.07.016_bib0605","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.2214\/AJR.07.2924","article-title":"MRI techniques for prediction of local tumor progression after high-intensity focused ultrasonic ablation of prostate cancer","volume":"190","author":"Kim","year":"2008","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.purol.2015.07.016_bib0610","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1007\/s00330-010-1879-3","article-title":"Whole-body MRI (WB-MRI) versus axial skeleton MRI (AS-MRI) to detect and measure bone metastases in prostate cancer (PCa)","volume":"20","author":"Lecouvet","year":"2010","journal-title":"Eur Radiol"},{"key":"10.1016\/j.purol.2015.07.016_bib0615","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/pros.21420","article-title":"Lymphatic spread of nodal metastases in high-risk prostate cancer: the ascending pathway from the pelvis to the retroperitoneum","volume":"72","author":"Briganti","year":"2012","journal-title":"Prostate"},{"key":"10.1016\/j.purol.2015.07.016_bib0620","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1007\/s00259-009-1157-2","article-title":"Validation of sentinel lymph node dissection in prostate cancer: experience in more than 2000\u00a0patients","volume":"36","author":"Holl","year":"2009","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.purol.2015.07.016_bib0625","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.ejso.2008.04.007","article-title":"Radioisotope guided sentinel lymph node dissection in patients with localized prostate cancer: results of the first 100\u00a0cases","volume":"35","author":"Bastide","year":"2009","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.purol.2015.07.016_bib0630","first-page":"501","article-title":"[Feasibility and value of the isotope sentinel node mapping technique in prostate cancer]","volume":"14","author":"Bastide","year":"2004","journal-title":"Prog Urol"},{"key":"10.1016\/j.purol.2015.07.016_bib0635","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.eururo.2012.06.057","article-title":"Mapping of pelvic lymph node metastases in prostate cancer","volume":"63","author":"Joniau","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.purol.2015.07.016_bib0640","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/iju.12184","article-title":"Sentinel lymph node dissection in more than 1200\u00a0prostate cancer cases: rate and prediction of lymph node involvement depending on preoperative tumor characteristics","volume":"21","author":"Winter","year":"2014","journal-title":"Int J Urol"},{"key":"10.1016\/j.purol.2015.07.016_bib0645","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1097\/PAS.0b013e3182556dcd","article-title":"Do adenocarcinomas of the prostate with Gleason score (GS)\u22646\u00a0have the potential to metastasize to lymph nodes?","volume":"36","author":"Ross","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.purol.2015.07.016_bib0650","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.eururo.2004.07.017","article-title":"Is there a need for pelvic lymph node dissection in low risk prostate cancer patients prior to definitive local therapy?","volume":"47","author":"Weckermann","year":"2005","journal-title":"Eur Urol"},{"key":"10.1016\/j.purol.2015.07.016_bib0655","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/j.eururo.2006.08.049","article-title":"Limitations of radioguided surgery in high-risk prostate cancer","volume":"51","author":"Weckermann","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.purol.2015.07.016_bib0660","doi-asserted-by":"crossref","DOI":"10.1016\/j.eururo.2013.09.025","article-title":"More extensive pelvic lymph node dissection improves survival in patients with node-positive prostate cancer","author":"Abdollah","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.purol.2015.07.016_bib0665","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.eururo.2014.05.011","article-title":"More extensive pelvic lymph node dissection improves survival in patients with node-positive prostate cancer","volume":"67","author":"Abdollah","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.purol.2015.07.016_bib0670","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.eururo.2014.07.014","article-title":"Optimisation of fluorescence guidance during robot-assisted laparoscopic sentinel node biopsy for prostate cancer","volume":"66","author":"KleinJan","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.purol.2015.07.016_bib0675","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.3892\/or.2014.3011","article-title":"Incidental prostate (1)(8)F-FDG uptake without calcification indicates the possibility of prostate cancer","volume":"31","author":"Seino","year":"2014","journal-title":"Oncol Rep"},{"issue":"Suppl. 1","key":"10.1016\/j.purol.2015.07.016_bib0680","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1007\/s00259-013-2358-2","article-title":"18F-Choline, 11C-choline and 11C-acetate PET\/CT: comparative analysis for imaging prostate cancer patients","volume":"40","author":"Brogsitter","year":"2013","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.purol.2015.07.016_bib0685","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.1158\/1078-0432.CCR-10-2093","article-title":"The sensitivity of [11C]choline PET\/CT to localize prostate cancer depends on the tumor configuration","volume":"17","author":"Souvatzoglou","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.purol.2015.07.016_bib0690","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.eururo.2012.09.039","article-title":"Utility of choline positron emission tomography\/computed tomography for lymph node involvement identification in intermediate- to high-risk prostate cancer: a systematic literature review and meta-analysis","volume":"63","author":"Evangelista","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.purol.2015.07.016_bib0695","doi-asserted-by":"crossref","first-page":"20","DOI":"10.2478\/raon-2013-0049","article-title":"Consequence of the introduction of routine FCH PET\/CT imaging for patients with prostate cancer: a dual centre survey","volume":"48","author":"Hodolic","year":"2014","journal-title":"Radiol Oncol"},{"key":"10.1016\/j.purol.2015.07.016_bib0700","doi-asserted-by":"crossref","first-page":"7673","DOI":"10.1158\/1078-0432.CCR-11-2048","article-title":"Use of [11C]choline PET-CT as a noninvasive method for detecting pelvic lymph node status from prostate cancer and relationship with choline kinase expression","volume":"17","author":"Contractor","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.purol.2015.07.016_bib0705","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.eururo.2008.04.030","article-title":"11C-choline positron emission tomography\/computerized tomography for preoperative lymph-node staging in intermediate-risk and high-risk prostate cancer: comparison with clinical staging nomograms","volume":"54","author":"Schiavina","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.purol.2015.07.016_bib0710","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1111\/j.1464-410X.2012.11150.x","article-title":"[18F]fluoromethylcholine (FCH) positron emission tomography\/computed tomography (PET\/CT) for lymph node staging of prostate cancer: a prospective study of 210\u00a0patients","volume":"110","author":"Poulsen","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.purol.2015.07.016_bib0715","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1111\/j.1464-410X.2012.11123.x","article-title":"Combined 18F-fluorocholine and 18F-fluoride positron emission tomography\/computed tomography imaging for staging of high-risk prostate cancer","volume":"110","author":"Kjolhede","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.purol.2015.07.016_bib0720","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1053\/j.semnuclmed.2009.05.003","article-title":"Prostate cancer: role of SPECT and PET in imaging bone metastases","volume":"39","author":"Beheshti","year":"2009","journal-title":"Semin Nucl Med"},{"issue":"Suppl. 2","key":"10.1016\/j.purol.2015.07.016_bib0725","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1016\/S1166-7087(13)70048-4","article-title":"[CCAFU recommendations 2013: prostate cancer]","volume":"23","author":"Salomon","year":"2013","journal-title":"Prog Urol"},{"key":"10.1016\/j.purol.2015.07.016_bib0730","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/RLU.0b013e3182867f3c","article-title":"Choline PET or PET\/CT and biochemical relapse of prostate cancer: a systematic review and meta-analysis","volume":"38","author":"Evangelista","year":"2013","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.purol.2015.07.016_bib0735","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1007\/s00259-014-2872-x","article-title":"Impact of 11C-choline PET\/CT on clinical decision making in recurrent prostate cancer: results from a retrospective two-centre trial","volume":"41","author":"Ceci","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.purol.2015.07.016_bib0740","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1007\/s00259-013-2655-9","article-title":"11C-choline PET\/CT detects the site of relapse in the majority of prostate cancer patients showing biochemical recurrence after EBRT","volume":"41","author":"Ceci","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.purol.2015.07.016_bib0745","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.juro.2012.09.001","article-title":"[11C]choline positron emission tomography\/computerized tomography for early detection of prostate cancer recurrence in patients with low increasing prostate specific antigen","volume":"189","author":"Giovacchini","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2015.07.016_bib0750","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.2967\/jnumed.114.138313","article-title":"Early biochemical relapse after radical prostatectomy: which prostate cancer patients may benefit from a restaging 11C-Choline PET\/CT scan before salvage radiation therapy?","volume":"55","author":"Castellucci","year":"2014","journal-title":"J Nucl Med"},{"key":"10.1016\/j.purol.2015.07.016_bib0755","doi-asserted-by":"crossref","first-page":"833","DOI":"10.2967\/jnumed.112.110148","article-title":"Impact of 18F-choline PET\/CT in prostate cancer patients with biochemical recurrence: influence of androgen deprivation therapy and correlation with PSA kinetics","volume":"54","author":"Beheshti","year":"2013","journal-title":"J Nucl Med"},{"key":"10.1016\/j.purol.2015.07.016_bib0760","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00259-011-2030-7","article-title":"Influence of PSA, PSA velocity and PSA doubling time on contrast-enhanced 18F-choline PET\/CT detection rate in patients with rising PSA after radical prostatectomy","volume":"39","author":"Schillaci","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.purol.2015.07.016_bib0765","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/RLU.0b013e31823363b0","article-title":"Prostate-specific antigen velocity versus prostate-specific antigen doubling time for prediction of 11C choline PET\/CT in prostate cancer patients with biochemical failure after radical prostatectomy","volume":"37","author":"Giovacchini","year":"2012","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.purol.2015.07.016_bib0770","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.eururo.2012.08.003","article-title":"18F-Fluoroethylcholine PET\/CT identifies lymph node metastasis in patients with prostate-specific antigen failure after radical prostatectomy but underestimates its extent","volume":"63","author":"Tilki","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.purol.2015.07.016_bib0775","doi-asserted-by":"crossref","first-page":"38e9","DOI":"10.1016\/j.urolonc.2013.03.006","article-title":"Utility of [11C]choline PET\/CT in guiding lesion-targeted salvage therapies in patients with prostate cancer recurrence localized to a single lymph node at imaging: results from a pathologically validated series","volume":"32","author":"Passoni","year":"2014","journal-title":"Urol Oncol"},{"key":"10.1016\/j.purol.2015.07.016_bib0780","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.eururo.2012.09.001","article-title":"The promise of choline-PET\/CT in the detection of recurrent prostate cancer: what are the limits of our investigation?","volume":"63","author":"Schiavina","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.purol.2015.07.016_bib0785","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/MNM.0000000000000040","article-title":"Meta-analysis of (11)C-choline and (18)F-choline PET\/CT for management of patients with prostate cancer","volume":"35","author":"von Eyben","year":"2014","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.purol.2015.07.016_bib0790","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2967\/jnumed.113.123380","article-title":"11C-choline PET\/CT predicts prostate cancer-specific survival in patients with biochemical failure during androgen-deprivation therapy","volume":"55","author":"Giovacchini","year":"2014","journal-title":"J Nucl Med"},{"key":"10.1016\/j.purol.2015.07.016_bib0795","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.eururo.2011.07.060","article-title":"Pelvic\/retroperitoneal salvage lymph node dissection for patients treated with radical prostatectomy with biochemical recurrence and nodal recurrence detected by [11C]choline positron emission tomography\/computed tomography","volume":"60","author":"Rigatti","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.purol.2015.07.016_bib0800","first-page":"1270","article-title":"(11)C-Choline PET\/CT as a guide to radiation treatment planning of lymph-node relapses in prostate cancer patients","volume":"41","author":"Picchio","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"Suppl. 1","key":"10.1016\/j.purol.2015.07.016_bib0805","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1007\/s00259-013-2398-7","article-title":"Influence of androgen deprivation therapy on choline PET\/CT in recurrent prostate cancer","volume":"40","author":"Dost","year":"2013","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.purol.2015.07.016_bib0810","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s00345-012-0908-z","article-title":"Impact of total PSA, PSA doubling time and PSA velocity on detection rates of 11C-Choline positron emission tomography in recurrent prostate cancer","volume":"31","author":"Rybalov","year":"2013","journal-title":"World J Urol"},{"key":"10.1016\/j.purol.2015.07.016_bib0815","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/bju.12545","article-title":"Hemi salvage high-intensity focused ultrasound (HIFU) in unilateral radiorecurrent prostate cancer: a prospective two-centre study","volume":"114","author":"Baco","year":"2014","journal-title":"BJU Int"},{"key":"10.1016\/j.purol.2015.07.016_bib0820","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.canrad.2014.06.002","article-title":"[Salvage treatments following prostate radiation therapy: role of the urologist]","volume":"18","author":"Souli\u00e9","year":"2014","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.purol.2015.07.016_bib0825","doi-asserted-by":"crossref","DOI":"10.1016\/j.eururo.2015.01.013","article-title":"Can clinically significant prostate cancer be detected with multiparametric magnetic resonance imaging? A systematic review of the literature","author":"Futterer","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.purol.2015.07.016_bib0830","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00259-013-2560-2","article-title":"Evaluation of the PET component of simultaneous [(18)F]choline PET\/MRI in prostate cancer: comparison with [(18)F]choline PET\/CT","volume":"41","author":"Wetter","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.purol.2015.07.016_bib0835","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1007\/s00259-013-2467-y","article-title":"Comparison of integrated whole-body [11C]choline PET\/MR with PET\/CT in patients with prostate cancer","volume":"40","author":"Souvatzoglou","year":"2013","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"Suppl 1","key":"10.1016\/j.purol.2015.07.016_bib0840","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1007\/s00259-013-2445-4","article-title":"PET\/MR in prostate cancer: technical aspects and potential diagnostic value","volume":"40","author":"Souvatzoglou","year":"2013","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.purol.2015.07.016_bib0845","doi-asserted-by":"crossref","first-page":"103718","DOI":"10.1155\/2014\/103718","article-title":"Value of fused 18F-Choline-PET\/MRI to evaluate prostate cancer relapse in patients showing biochemical recurrence after EBRT: preliminary results","volume":"2014","author":"Piccardo","year":"2014","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.purol.2015.07.016_bib0850","doi-asserted-by":"crossref","first-page":"546","DOI":"10.2967\/jnumed.111.091421","article-title":"Introducing parametric fusion PET\/MRI of primary prostate cancer","volume":"53","author":"Park","year":"2012","journal-title":"J Nucl Med"},{"key":"10.1016\/j.purol.2015.07.016_bib0855","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1007\/s00259-014-2786-7","article-title":"Potential of hybrid (1)(8)F-fluorocholine PET\/MRI for prostate cancer imaging","volume":"41","author":"de Perrot","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.purol.2015.07.016_bib0860","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1007\/s00330-014-3240-8","article-title":"Preoperative lymph node staging in patients with primary prostate cancer: comparison and correlation of quantitative imaging parameters in diffusion-weighted imaging and 11C-choline PET\/CT","volume":"24","author":"Vag","year":"2014","journal-title":"Eur Radiol"},{"key":"10.1016\/j.purol.2015.07.016_bib0865","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.clgc.2013.08.002","article-title":"18F-FACBC compared with 11C-choline PET\/CT in patients with biochemical relapse after radical prostatectomy: a prospective study in 28\u00a0patients","volume":"12","author":"Nanni","year":"2014","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.purol.2015.07.016_bib0870","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00259-013-2525-5","article-title":"Comparison of PET imaging with a (68)Ga-labelled PSMA ligand and (18)F-choline-based PET\/CT for the diagnosis of recurrent prostate cancer","volume":"41","author":"Afshar-Oromieh","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["Progr\u00e8s en Urologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1166708715002353?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1166708715002353?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T06:27:34Z","timestamp":1761114454000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1166708715002353"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":87,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S1166708715002353"],"URL":"https:\/\/doi.org\/10.1016\/j.purol.2015.07.016","relation":{},"ISSN":["1166-7087"],"issn-type":[{"value":"1166-7087","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Imagerie du cancer de la prostate\u00a0: IRM et imagerie nucl\u00e9aire","name":"articletitle","label":"Article Title"},{"value":"Progr\u00e8s en Urologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.purol.2015.07.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}